Related Experiment Video
Updated: Aug 17, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Factors influencing the development of a hepatitis C exercise protocol: a literature review
Mary Ann Gapinski1, Donna M Zucker
1F. W. Parker Charter Essential School, Devens, Massachusetts 01434, USA. maryann@parker.org
Abstract:
Chronic hepatitis C (HCV) varies greatly in its course and outcomes. Reports of fatigue and other symptoms are common during treatment and when patients are not receiving treatment. Exercise as a form of treatment for HCV-related fatigue has had little attention in research studies, yet data from studies in closely related chronic conditions consistently report the value of exercise for maintaining and improving health and reducing risk factors. This article examines the factors influencing the development of an exercise protocol as an adjunct to health promotion in patents with HCV. A review of the current literature summarizes findings from the areas of exercise in chronic illness states, exercise measures, and exercise prescription as treatment for chronic illnesses, with a focus on HCV. Nurses should consider these factors when developing an exercise protocol as an alternative treatment for side effects and symptoms related to hepatitis C and other chronic conditions. More research on specific exercise prescriptions should be undertaken and reported in the literature.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatic Drug Excretion: Influencing Factors
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Cirrhosis II: Pathophysiology